newest glp 1 drug New study shows popular GLP-1 weight loss may slow biological aging FDA approves Wegovy pill and

One could hypothesize that the weight loss benefit of these drugs can be, at least in part, extrapolated to patients with T1D as it is mainly driven by appetite suppression (14)

However, the authors noted prior evidence from studies like Bezin et al

In smaller acute metabolic studies with DPP-4 inhibitors, a reduction of the post-prandial rise in triglycerides, and apolipoprotein-B 48 was observed

GLP-1 agonists can cost $1,000 or more each month, and many insurance providers dont cover the cost when they're prescribed for weight loss

For comparison, nausea has been reported at approximately 44% in the Wegovy semaglutide trials and 28% in the Zepbound tirzepatide trials

Your doctor also may prescribe the drugs if your BMI is at least 27 and you have one or more weight-related health conditions, such as diabetes or high blood pressure